- Home
- / 21st Century Oncology
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
21st Century Oncology financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Total Funding
$650 M
Revenue
$263.1 M
FY, 2015
CreditSafe Score
?
Score changed on Jun 11, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2013 | FY, 2014 | FY, 2015 |
|---|---|---|---|
| Revenue | 736.5M | 1.0B | 263.1M |
| Revenue growth, % | 39.4% | -74.4% | |
| General and administrative expense | 106.9M | 135.3M | 68.3M |
| Operating expense total | 516.2M | 680.3M | 210.9M |
| Interest expense | 86.7M | 113.3M | 23.8M |
| Pre tax profit | (98.7M) | (338.1M) | |
| Income tax expense | (20.4M) | 5.2M | 2.9M |
| Net Income | (78.2M) | (343.2M) | (14.4M) |